NCT02304367 2024-05-06
Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Kyowa Kirin Co., Ltd.
Phase 2 Completed
Kyowa Kirin Co., Ltd.
University of Alabama at Birmingham
Kyowa Kirin Co., Ltd.